|
|
|
|
|
|
|
26.05.26 - 19:30
|
Merck Announces Third-Quarter 2026 Dividend (Business Wire)
|
|
|
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company's common stock for the third quarter of 2026. Payment will be made on July 8, 2026, to shareholders of record at the close of business on June 15, 2026.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every d...
|
|
|
|
|
|
|
26.05.26 - 06:12
|
TAGESVORSCHAU: Termine am 26. Mai 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 26. Mai^TERMINE UNTERNEHMEN08:00 GBR: Kingfisher, Q1-Umsatz10:00 DEU: Sparkassenverband Rheinland-Pfalz, Bilanz-Pk, Mainz15:00 USA: Merck & Co, HauptversammlungTERMINE ......
|
|
|
|
|
|
|
25.05.26 - 17:42
|
TAGESVORSCHAU: Termine am 26. Mai 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 26. Mai^TERMINE UNTERNEHMEN08:00 GBR: Kingfisher, Q1-Umsatz10:00 DEU: Sparkassenverband Rheinland-Pfalz, Bilanz-Pk, Mainz15:00 USA: Merck & Co, HauptversammlungTERMINE ......
|
|
|
|
|
|
|
21.05.26 - 13:24
|
Merck & Co Aktie: Patentpoker läuft (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse der Raiffeisen Bank International AG:
Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) und erhöht das Kursziel. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.05.26 - 14:06
|
Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor (Business Wire)
|
|
|
MENLO PARK, Calif.--(BUSINESS WIRE)--Patient Square Capital, a leading health care investment firm, today announced that Timothy P. Walbert has joined the firm as a Senior Advisor.
Mr. Walbert brings more than three decades of biopharmaceutical leadership experience and currently serves as Managing Partner of HRZN Partners LLC and a Senior Advisor to Amgen. Most recently, he was Chairman, President, and Chief Executive Officer of Horizon Therapeutics, which he grew to approximately $4 billion in annual sales prior to its $28.3 billion acquisition by Amgen in 2023; earlier, he led IDM Pharma Inc. through its acquisition by Takeda and held senior roles at Abbott (now AbbVie), where he led the global launch of HUMIRA®, as well as at G.D. Searle & Company, Merck & Co., and Wyeth.
“Patient Square Capital has built a highly differentiated platform and a strong record of partnering with management teams to create enduring value in health care,” said Tim Walbert. “I'm pleased to join the firm as a Senior ...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
